AIME has won the inaugural Pistoia Alliance Mini Start-Up Challenge following a closely fought contest. Alongside this, xRapid was also voted as the audience winner at the Pistoia Alliance European Conference, in London.
The Pistoia Alliance, an organization dedicated to improving global life sciences R&D, has announced the finalists of its inaugural Mini Start Up Challenge.
At the Pistoia Alliance we are continuing our growth with the arrival of a number of new members in the first quarter of 2016.
The Pistoia Alliance and quattro research GmbH are pleased to announce the release of a major new extension to the HELM notation standard and toolkit. The new functionality enables HELM to support the representation of biomolecules with some structural uncertainty or ambiguity.
The March 2016 edition of the Pistoia Alliance newsletter, Innovation in Action, is available to download as a PDF document.
The presentation and recording from the "SEND, the CDISC Standard for Exchange of Nonclinical Data" Pistoia Alliance Debates webinar held on Wednesday 16th March 2016 are available here.
Externalization has driven global integration applications that bring together multiple CRO and academic partners. Traditional technologies often fail in the complex security and high-latency networks required by these applications. The cloud would seem to be an ideal solution, but will it work in China?
Being an ontologist can be challenging at times. For starters, you have to try and explain to most people what an ontologist is. Typically, it's not one of the 'profession' options when completing online applications. Then there are the ontologies themselves. The truth is that working out which ontologies are reliable and unreliable, even having worked with them for years, can be difficult and it's often more art than science. For those new to the area this challenge can be overwhelming.
Delivering precision medicine through healthcare systems in the highly populated countries of Asia can pose great challenges. India in particular has a complex healthcare system involving public and private players, inadequate regulatory frameworks, and restrictions on the transfer of biological samples for use in overseas research studies. This article takes a glimpse at current systems, challenges and future prospects for rolling out precision medicine in India.